SCHEMBL10592256

SCHEMBL10592256

CC(C)(CNC(=O)CCCO[N+](=O)[O-])NCC(O)COc1cccc2[nH]c(=O)c(C#N)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 9/20 0.49
▸ ADRB2 P07550 4/20 0.49
▸ CYP1A2 P05177 3/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ CASR P41180 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SLC22A1 O15245 1/20 0.42
▸ ADRB1 P08588 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ADRB3 P13945 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADRA2B P18089 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10594731 0.98 CYP2D6 (0.48) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10503082 0.91 CYP2D6 (0.61) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10591715 0.90 CYP2D6 (0.38) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10505739 0.89 ADRB1 (0.44) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10506715 0.88 CYP2D6 (0.61) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10594583 0.88 CYP2D6 (0.37) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10504801 0.87 SLC6A2 (0.51) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10504268 0.86 ADRB2 (0.44) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19
SCHEMBL10503937 0.85 HTR1A (0.56) CYP2D6ADRB2CYP1A2CASRKDM4E
SCHEMBL10503050 0.84 ADRB2 (0.43) CYP2D6ADRB2CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback